Castellum, Inc. (NYSEAMERICAN:CTM – Get Free Report) saw a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 332,300 shares, an increase of 228.7% from the October 31st total of 101,100 shares. Based on an average trading volume of 1,470,000 shares, the short-interest ratio is currently 0.2 days. Currently, 1.1% of the shares of the company are short sold.
Castellum Stock Up 11.4 %
Shares of NYSEAMERICAN:CTM traded up $0.02 during trading on Wednesday, hitting $0.19. 1,148,011 shares of the company were exchanged, compared to its average volume of 863,702. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.63. Castellum has a 1-year low of $0.12 and a 1-year high of $0.40.
Institutional Trading of Castellum
An institutional investor recently raised its position in Castellum stock. Virtu Financial LLC increased its stake in Castellum, Inc. (NYSEAMERICAN:CTM – Free Report) by 82.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 103,288 shares of the company’s stock after purchasing an additional 46,606 shares during the quarter. Virtu Financial LLC owned approximately 0.19% of Castellum worth $27,000 at the end of the most recent quarter. 3.39% of the stock is owned by hedge funds and other institutional investors.
About Castellum
Castellum, Inc provides services in the areas of cybersecurity, information technology, electronic and information warfare, and information operations. Its services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model based systems engineering services.
Recommended Stories
- Five stocks we like better than Castellum
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Stock Analyst Ratings and Canadian Analyst Ratings
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is the Nikkei 225 index?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Castellum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castellum and related companies with MarketBeat.com's FREE daily email newsletter.